Related Experiment Videos
Toward improved glycemic control in diabetes. What's on the horizon?
1Department of Medicine, University of Cambridge, England.
Abstract:
It has now been firmly established that maintenance of good glycemic control can prevent or retard the development of the microvascular complications of type I (insulin-dependent) diabetes. Although not yet definitively established, it is likely that optimal control of plasma glucose will also assist in the prevention of such problems in type II (non-insulin-dependent) diabetes. While a limited range of therapeutic agents for the treatment of hyperglycemia is currently available, a number of newer therapies are currently undergoing evaluation. In this review, we provide an overview of such treatments and assess their likely place in the therapeutic armamentarium over the next few years.
Insights
Maintaining good blood glucose control is key for preventing diabetes complications. Newer therapies are emerging to improve hyperglycemia management in both type 1 and type 2 diabetes.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Pharmacology
Background:
- Good glycemic control prevents microvascular complications in type 1 diabetes.
- Optimal plasma glucose control likely benefits type 2 diabetes complication prevention.
- Current hyperglycemia treatments are limited, with new therapies under evaluation.
Purpose of the Study:
- To review emerging therapies for hyperglycemia.
- To assess the future role of new treatments in diabetes management.
Main Methods:
- Literature review of current and emerging diabetes therapies.
- Analysis of therapeutic agents for glycemic control.
- Assessment of potential clinical applications for new treatments.
Main Results:
- Established link between glycemic control and microvascular complication prevention in type 1 diabetes.
- Likely benefit of glycemic control for type 2 diabetes complication prevention.
- Identification of novel therapeutic agents undergoing evaluation.
Conclusions:
- Newer therapies show promise for improving hyperglycemia management.
- These emerging treatments may expand therapeutic options for diabetes.
- A comprehensive understanding of new agents is crucial for future clinical practice.